Sentence Production Training in Aphasia
Purdue University · with Temple University, University of California, San Diego · NCT05415501
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 21–85 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 104
- US sites recruiting
- 1
- Study start
- August 1, 2021
- Record last updated
- December 18, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This project focuses on developing a novel treatment for sentence production and comprehension in aphasia, using implicit priming. First set of experiments will aim examine which learning conditions are most effective in creating maximal training gains. Then, in a later study, the investigators will develop and test the efficacy of a novel treatment study based on findings from the first set of the studies.
Being studied: Sentence training
Conditions: Aphasia
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Individuals with post-stroke aphasia
- At least 6 months post-onset of eft hemisphere stroke
- Native speaker of English
- Normal or corrected to normal hearing and vision
- High-school educated
- Difficulty communicating in sentences, with some ability to use words independently
Exclusion Criteria
- Severe apraxia of speech
- Other neurological conditions affecting communication (e.g., dementia)
- Uncontrolled psychiatric/psychological conditions affecting thinking and communication
- Active alcohol/substance abuse
Recruiting US locations
Purdue University
West Lafayette, IN 47907
Site contact: Jiyeon Lee · 765-494-3810 · lee1704@purdue.edu
Study contacts (from the official record)
- Jiyeon Lee, PhD · 7654943810 · lee1704@purdue.edu
- Jiyeon Lee · 7654943810 · lee1704@purdue.edu
Similar studies in Indiana
All healthy volunteers studies in Indiana →- RecruitingHealthy volunteersEarly Phase 1Overnight stay mentioned
Interaction of CYP2B6 Genotype and Efavirenz With Methadone and Tizanidine PK
Indiana University
- Location
- Indianapolis, IN
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Plainfield, IN + 6 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Indianapolis, IN + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1/Phase 2
Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)
Atavistik Bio, Inc
- Location
- Indianapolis, IN + 5 other US sites
- Eligibility basics
- Ages 18+